| LC control no. | sh2019003668 |
|---|---|
| Topical heading | Off-label drug use |
| Variant(s) | Extra-label drug use Off-label prescribing |
| See also | Drug utilization Drugs--Prescribing |
| Scope note | Here are entered works on drug or vaccine use or prescription outside their approved dosage or purpose. |
| Found in | Work cat: United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations. Off-label drug use and FDA review of supplemental drug applications, 1998: p. 1 (off-label use of prescription medications; use of a drug for additional indications, additional patients, or at a different dosage level than originally approved; extra-label drug use; off-label use; off-label drug) MeSH, May 7, 2019 (off-label use: the practice of prescribing or using a drug or a vaccine outside the scope of the drug's official approved label as designated by a regulatory agency concerning the treatment of a particular disease or condition; entry terms: dose-sparing drug use, fractional dose drug use, off-label prescribing, reduced-dose drug use, unlabeled indication; see also: drug approval, drug labeling, drug utilization) Merriam-Webster online, May 7, 2019 (off-label; of, relating to, or being a drug used to treat a condition for which it has not been officially approved) The journal of law, medicine & ethics, Fall 2009: p. 476 (off-label prescribing; off-label use) Mayo Clinic. Mayo Clinic proceedings, Oct. 2012: p. 982 (off-label drug use; OLDU) p. 989 (practitioners are typically forced to use medications in an off-label manner to treat rare, or orphan, diseases; orphan drugs are often a subtype of OLDU) |
| Not found in | Web. 3; Encyclopedia & dictionary of medicine, nursing, & allied health (5th ed.) |
 |  |  |